Coalition for Imaging & Bioengineering Research | Academy of Radiology Research
CIBR members attended the National Institutes of Health and the Food and Drug Administration Joint Leadership Council Stakeholders Meeting on June 2. CIBR also submitted comments recommending that the Council elevate the urgency of developing a regulatory pathway to accelerate the rapid and efficient clinical translation of diagnostic and therapeutic biomarkers. To view the comments submitted please click here.
Advocate for consistent federal funding from Congress to the National Institutes of Health
Dramatically broaden awareness of the value of imaging and bioengineering research
Facilitate awareness and accessibility of resources containing pertinent information for Members of Congress and the imaging community in general